Endocrine forms of hypertension
treatment of endocrine hypertension Arterial hypertension
primary forms of hypertension
identification of patients
Detection of secondary forms of hypertension
increased cardiovascular risk
hypertensive patients
thirds of patients
identification of endocrine causes
specific endocrine groups
prevention of cardiovascular complications
specific omics profiles
Omics-based profiling
Application of omics
blood pressure regulation
blood pressure control
PPGL
curative treatment
underlying disease
personalised treatment
metabolic risk
cerebrovascular disease
based strategies
metabolic complications
stratified health promotion program
stratified approaches of health promotion
increased production of hormones
ischemic heart disease
primary aldosteronism
Established profiles
metabolomics data
major targets
improved diagnosis
genomics
high throughput genetics
phenome annotations
pheochromocytoma
hypertensives
key
targeted management
functional paraganglioma
cluster
large therapeutic arsenal
bioinformatics modelling
Cushingâ€™s syndrome
preclinical phenotypes
group of adrenal disorders
screening
diminished quality of life
efficient therapy
stratification biomarkers
small increments
general population
deaths
year
diseases
project